10-K: Dow Inc. Reports Significant 2025 Loss Amidst Market Downturn

Dow Inc. posted a substantial net loss in 2025, driven by declining sales, goodwill impairment, and extensive restructuring efforts in a challenging macroeconomic environment.

Summary

• Net sales for 2025 were $39.97 billion, a 7% decrease from $42.96 billion in 2024, with local price down 7% across all operating segments and geographic regions.
• The company reported a net loss available for Dow Inc. common stockholders of $2.62 billion in 2025, a significant reversal from net income of $1.12 billion in 2024.
• Earnings per share (EPS) for Dow Inc. was a loss of $3.70 in 2025, compared to earnings of $1.57 in 2024.
• Operating EBIT decreased to $422 million in 2025 from $2.59 billion in 2024, reflecting margin compression and lower equity earnings.
• Restructuring, goodwill impairment, and asset-related charges totaled $1.86 billion in 2025, including a $690 million goodwill impairment for the Polyurethanes & Construction Chemicals unit and a $303 million asset impairment in Latin America.
• Equity in losses of nonconsolidated affiliates increased to $240 million in 2025 from $6 million in 2024, primarily due to integrated margin compression at joint ventures.
• The quarterly dividend was reduced by 50% to $0.35 per share starting in the third quarter of 2025.
• The 'Transform to Outperform' program, announced in January 2026, is expected to deliver at least $2 billion in near-term Operating EBITDA improvement and includes a workforce reduction of approximately 4,500 roles.
• The Fort Saskatchewan Path2Zero project in Alberta, Canada, has been delayed by two years, with phases now expected to start up by the end of 2029 and 2030.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a significantly negative report, reflecting a challenging macroeconomic environment, substantial financial losses, and strategic project delays, despite ongoing efforts in cost reduction and sustainability.

Positives

• Completed construction of a world-scale polyethylene unit on the U.S. Gulf Coast in 2025, enhancing specialty packaging, health and hygiene, and industrial/consumer packaging capabilities.
• Expanded propylene glycol capacity at the Map Ta Phut, Thailand, joint venture by 80,000 metric tons per year, reaching 250,000 metric tons per year, making it the largest in the region.
• Successfully completed investments to expand alkoxylation capacity in the United States and mechanically completed investments in Europe, collectively increasing global capacity by 70% compared to the 2020 baseline.
• Received approximately $3 billion from the sale of a 49% minority stake in Diamond Infrastructure Solutions to InfraPark Holdings, LLC.
• Received a judgment ordering Nova Chemicals Corporation to pay an additional $1.62 billion Canadian dollars (approximately $1.2 billion U.S. dollars) for damages incurred through June 2018, with an additional $100 million U.S. dollars in awarded fees.
• Maintained a strong financial position with $13.6 billion in cash and committed/available liquidity at December 31, 2025, and no substantive long-term debt maturities until 2029.
• Achieved an Occupational Safety and Health Administration Total Recordable Injury and Illness Rate of 0.20 in 2025, demonstrating strong safety performance.
• Recognized as a 'World's Best Workplace' for the third consecutive year and ranked #1 on the 'Best Workplaces in Manufacturing & Production' for the second consecutive year by Great Place to Work® and Fortune.

Negatives

• Net sales decreased by 7% to $39.97 billion in 2025 from $42.96 billion in 2024, with local price declines across all segments and regions.
• Reported a net loss of $2.62 billion in 2025, a significant decline from net income of $1.12 billion in 2024.
• Earnings per share (EPS) was a loss of $3.70 in 2025, compared to earnings of $1.57 in 2024.
• Operating EBIT decreased significantly across all segments, with Industrial Intermediates & Infrastructure reporting a loss of $561 million in 2025 compared to income of $125 million in 2024.
• Recognized a goodwill impairment charge of $690 million for the Polyurethanes & Construction Chemicals reporting unit.
• Incurred a pretax impairment charge of $303 million related to chlor-alkali, propylene oxide, and brine production assets in Latin America.
• Equity in losses of nonconsolidated affiliates increased substantially to $240 million in 2025 from $6 million in 2024.
• The quarterly dividend was reduced by 50% to $0.35 per share, reflecting a challenging macroeconomic environment.
• Announced workforce reductions of approximately 1,500 roles in Q1 2025 and an additional 4,500 roles under the 'Transform to Outperform' program.
• The world's first net-zero Scope 1 and 2 CO2e emissions integrated ethylene cracker and derivatives complex in Alberta, Canada (Path2Zero project), experienced a two-year delay in completion.
• Plans to shut down an ethylene cracker in Bhlen, Germany, and certain chlor-alkali and vinyl assets in Schkopau, Germany, by the end of 2027.
• Plans to shut down a basics siloxanes plant in Barry, United Kingdom, by mid-year 2026.
• Interest expense increased to $865 million in 2025 from $811 million in 2024.
• Credit ratings for The Dow Chemical Company were downgraded by Moody's (Baa1 to Baa2) and Fitch (BBB+ to BBB, F1 to F2), with Moody's maintaining a negative outlook.

Risks

• Climate change-related risks, including legal/regulatory responses, failure to meet carbon neutrality commitments, increased costs, reputational damage, and reduced product demand.
• Macroeconomic conditions, such as market volatility, credit availability, changes in credit ratings, global competition, trade policies (tariffs, import/export controls), geopolitical conflicts (Russia-Ukraine, Middle East), inflation, and interest/currency exchange rate fluctuations.
• Increased obligations and expenses related to defined benefit pension plans and other postretirement benefit plans.
• Cyclical nature of the chemical industry's supply-demand balance, leading to excess capacity, downward pressure on prices, and decreased operating rates.
• Costs of complying with evolving environmental regulatory requirements and potential restrictions on plant operations or civil/criminal sanctions from violations.
• Increased concerns regarding the safe use of chemicals and plastics, potentially leading to more restrictive regulations, demand for substitute materials, and reduced demand for plastic products.
• Litigation risks, including a large number of asbestos-related suits against Union Carbide Corporation (liability of $708 million at December 31, 2025), securities class actions, and shareholder derivative actions.
• Operational and strategic risks associated with implementing the company's strategy in emerging regions, including political instability, expropriation, and supplier non-performance.
• Cybersecurity threats, including disruption of IT systems, data breaches, loss of proprietary information, and risks related to the expanding utilization of AI.
• Goodwill impairment, particularly if weak demand or market conditions persist, as evidenced by the $690 million impairment charge in 2025.
• Significant operational events such as natural disasters, severe weather, cyberattacks, or public health crises, which could disrupt manufacturing, supply chains, and workforce.
• Volatility in raw material and energy costs, which account for a substantial portion of production costs and can impact earnings if price increases cannot be passed on to customers.

Future Outlook

The company anticipates continued volume growth in Packaging & Specialty Plastics, driven by global polyethylene demand and new capacity, though local prices will be influenced by market dynamics. Industrial Intermediates & Infrastructure expects improved volume growth from capacity expansions, with stable local prices. Performance Materials & Coatings will focus on high-growth performance silicones, benefiting from AI and data centers, with stable specialty product pricing. Overall, market conditions for coatings are expected to improve in the second half of 2025 due to central bank rate cuts. Capital expenditures are projected at $2.5 billion for 2026, including the delayed Fort Saskatchewan Path2Zero project. The 'Transform to Outperform' program is expected to yield at least $2 billion in near-term Operating EBITDA improvement.

Management Comments

• "Team Dow remains focused on delivering near-term cost savings, navigating an unprecedented industry downturn and its long-standing cultural values of safety and reliability."
• "By reducing complexity, adopting the best available technologies and streamlining end-to-end processes, Transform to Outperform is expected to provide step-change productivity gains while enabling consistent growth."
• "The Company will make breakthrough improvements to fundamentally simplify Dows operating model, which will position the Company to work more efficiently, better serve customers and deliver improved shareholder returns."
• "The adjustment to the size of the dividend reflects the Companys balanced capital allocation approach and enhances financial flexibility amidst a persistently challenging macroeconomic environment."
• "Dow remains committed to its Path2Zero project and the growth upside it will enable in targeted applications like pressure pipe, wire and cable, and food packaging."

Industry Context

StockSavvy.ai notes that Dow's 2025 performance reflects broader challenges in the chemical industry, including significant overcapacity and slower global GDP growth, which have led to margin compression and lower prices. The company's strategic focus on decarbonization, circular economy solutions, and high-growth end-markets like data centers and electric vehicles aligns with long-term industry trends towards sustainability and advanced materials, positioning it for future recovery despite current headwinds. The delay in the Path2Zero project highlights the capital intensity and execution risks inherent in large-scale decarbonization initiatives within the sector.

Comparison to Industry Standards

• The company's performance was negatively impacted by 'industry overcapacity and newer entrants exporting at anti-competitive economics,' suggesting a challenging competitive landscape.
• The Packaging & Specialty Plastics segment's participation in the entire ethylene-to-polyethylene chain integration provides 'industry-leading feedstock and derivative flexibility,' aiming to optimize returns and reduce earnings volatility compared to competitors.
• The Polyurethanes business is identified as the 'world's largest producer of propylene oxide, propylene glycol and polyether polyols,' indicating a leading market position in these specific chemical intermediates.
• Dow is recognized as 'one of the world's largest plastics producers,' emphasizing its scale and market presence.
• The company achieved an Occupational Safety and Health Administration Total Recordable Injury and Illness Rate of 0.20 in 2025, which is presented as an 'industry-leading result' in EH&S performance.
• Dow was honored as one of the 'World's Best Workplaces' for the third consecutive year and ranked #1 on the 'Best Workplaces in Manufacturing & Production' for the second consecutive year by Great Place to Work® and Fortune, indicating strong internal culture and employee satisfaction relative to peers.

Management Changes

Corporate Governance

Legal Proceedings

• Union Carbide Corporation, a wholly owned subsidiary, is involved in a large number of asbestos-related suits, with a total asbestos-related liability of $708 million at December 31, 2025.
• A putative securities class action was filed on August 29, 2025, alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 against the Company and certain officers for alleged false and misleading statements regarding macroeconomic and competitive pressures, softening demand, and dividend sustainability.
• Four putative shareholder derivative actions were filed in September and November 2025, based on the same alleged facts as the securities class action, naming officers and directors as defendants, and seeking damages on behalf of the Company; these actions are stayed pending resolution of the securities class action.
• A consent decree was approved on December 18, 2024, for the Lower Passaic River Study Area Superfund Site, requiring Essex Chemical Corporation (a Dow subsidiary) to contribute $1.15 million to a collective $150 million payment; the decision is currently under appeal.
• On January 3, 2025, the EPA formally alleged 21 violations of Risk Management Program (RMP) and Clean Air Act requirements at the Company's Louisiana Operations following an incident on July 14, 2023; discussions with the EPA are ongoing.
• On September 29, 2025, the EPA informed the Company of its intention to seek a civil penalty for benzene emissions in Orange, Texas, alleged to be in excess of action levels set out in an existing 2021 consent decree; discussions are ongoing.
• On October 14, 2025, the EPA demanded payment of $329,000 in stipulated penalties from Dow Silicones Corporation for self-reported violations under a January 24, 2020 consent decree.
• On June 10, 2025, the Court of King's Bench of Alberta, Canada, ordered Nova Chemicals Corporation to pay an additional $1.62 billion Canadian dollars (approximately $1.2 billion U.S. dollars) for damages incurred through June 2018, with an additional $100 million U.S. dollars in awarded fees on August 11, 2025; Nova has requested a stay of execution pending appeal, and Dow has filed another lawsuit for damages after June 2018.

Related Party Transactions

• The Dow Chemical Company (TDCC) declared $1,491 million and paid $1,503 million in dividends to Dow Inc. in 2025 to fund Dow Inc.'s dividends to common stockholders and share repurchases, and certain governance expenses, through intercompany loans.
• The Company sells excess ethylene glycol and ethylene to MEGlobal, a subsidiary of EQUATE (a 42.5% owned nonconsolidated affiliate), which represented 1% and 2% of total net sales and Packaging & Specialty Plastics segment sales, respectively, in 2025.
• The Company markets a significant portion of Sadara Chemical Company's (a 35% owned nonconsolidated affiliate) products outside the Middle East, with purchases of Sadara products representing 5% of 'Cost of sales' in 2025.
• The Company purchases products from The SCGC-Dow Group (a 50% owned nonconsolidated affiliate) for marketing and distribution in Asia Pacific, representing 2% of 'Cost of sales' in 2025.
• TDCC has provided a guarantee of up to approximately $1.3 billion of Sadara's project financing debt, proportionate to its 35% ownership interest, and it is now probable that future performance under this guarantee will be required due to uncertainty in Sadara's short-term cash flows.
• Sadara drew $80 million under a $500 million revolving credit facility guaranteed by Dow in the fourth quarter of 2025, and it is probable that Dow will be required to perform on this obligation upon the facility's expiration in the second quarter of 2026.

Stakeholder Impact

• Shareholders face negative impacts from the significant net loss, 50% dividend reduction, goodwill and asset impairments, and ongoing litigation, though potential positive cash inflow from the Nova Chemicals judgment could partially offset this.
• Employees are impacted by announced workforce reductions of approximately 1,500 roles in Q1 2025 and an additional 4,500 roles under the 'Transform to Outperform' program, but benefit from the company's commitment to safety, well-being, and recognition as a 'World's Best Workplace'.
• Customers may benefit from new product offerings and expanded capacities in polyethylene and alkoxylation, as well as the company's focus on sustainable and low-carbon solutions.
• Creditors face increased risk perception due to credit rating downgrades from Moody's and Fitch, although the company maintains strong liquidity and no substantive long-term debt maturities until 2029.
• Communities near manufacturing sites may experience impacts from planned asset shutdowns in Germany and the UK, as well as ongoing environmental remediation efforts and legal proceedings related to environmental contamination.

Next Steps

• Complete the 'Transform to Outperform' program, expected to deliver at least $2 billion near-term Operating EBITDA improvement, with associated costs of $1.1 billion to $1.5 billion, including severance for approximately 4,500 roles, primarily over the next two years.
• Continue construction of the Fort Saskatchewan Path2Zero project, with phases expected to start up by the end of 2029 and 2030.
• Complete the shutdown of a basics siloxanes plant in Barry, United Kingdom, by mid-year 2026.
• Shut down an ethylene cracker in Bhlen, Germany, by the end of 2027.
• Shut down certain chlor-alkali and vinyl assets in Schkopau, Germany, by the end of 2027.
• Capital expenditures are expected to be approximately $2.5 billion in 2026.
• Cash contributions to pension plans are expected to be approximately $180 million in 2026.
• Cash outflows related to the 2025 Restructuring Program are expected to be approximately $260 million.
• Cash inflows related to the Nova Chemicals Corporation judgment are expected to be approximately $1.3 billion.
• Cash outflows for dividends paid to noncontrolling interests are expected to be approximately $250 million.
• Continue ongoing discussions with the EPA regarding alleged RMP violations in Louisiana and civil penalties for benzene emissions in Orange, Texas.
• Payment of $329,000 in stipulated penalties to the EPA for Dow Silicones Corporation to resolve violations and prior to termination of consent decree.
• Await decision from the Court of Appeal of Alberta regarding Nova Chemicals Corporation's request for a stay on the $1.2 billion USD judgment.
• Pursue another lawsuit against Nova Chemicals Corporation for damages due to lost ethylene after June 2018.

Key Dates

Recommendation

The filing reveals a substantial net loss, significant impairment charges, a 50% dividend cut, and large-scale workforce reductions, all indicative of severe operational and market challenges. While strategic investments in sustainability and some legal wins offer long-term potential, the immediate financial performance and ongoing macroeconomic headwinds suggest a difficult period ahead, warranting a 'Sell' recommendation for seasoned investors.

Keywords

Chemicals, Materials Science, Plastics, Polyethylene, Ethylene, Polyurethanes, Coatings, Industrial Intermediates, Infrastructure, Sustainability, Decarbonization, Circular Economy, Advanced Recycling, Net-Zero Emissions, SEC Filing, 10-K, Financial Results, Risk Factors, Corporate Governance, Restructuring, Impairment, Dividends, Capital Expenditures, Nova Chemicals, Asbestos Litigation, Environmental Compliance